NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024
Estimated value
£580.2m
Awarded value
£688.0m
Suppliers
1
Lots
1
Published
26 Feb 2024
Description
Project Title: NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024 Offer reference number: CM/PHR/22/5678 CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B. Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A. Period of framework: 1 March 2024 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B). Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months
Scope
- Reference
- CF-2202100D0O000000rwimUAA
- Total value
- £580,156,000 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 01 Mar 2024 to 30 Aug 2026
- CPV classifications
- 33600000
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 22 Nov 2023, 1:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£688.0m
Award date
26 Jan 2024
Contract start
01 Mar 2024
Contract end
30 Aug 2026